Suppression of tunicamycin-induced CD44v6 ectodomain shedding and apoptosis is correlated with temporal expression patterns of active ADAM10, MMP-9 and MMP-13 proteins in Caki-2 renal carcinoma cells

Oncology Reports

Volumn 28, Issue 5, 2012, Pages 1869-1874

  Kim, Yeoun Hee ^a   Jung, Jae Chang ^a  

^a Kyungpook National University   (South Korea)

Author keywords

ADAM10; Apoptosis; CD44v6; MMP 9 13; Tunicamycin

Indexed keywords

ADAM10 ENDOPEPTIDASE; CASPASE 3; CD44V6 ANTIGEN; COLLAGENASE 3; GELATINASE B; GI 254023X; GLUCOSE REGULATED PROTEIN 78; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; ILOMASTAT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN INHIBITOR; TUNICAMYCIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; ENZYME REGULATION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; UPREGULATION;

ADAM PROTEINS; AMYLOID PRECURSOR PROTEIN SECRETASES; ANTI-BACTERIAL AGENTS; ANTIGENS, CD44; APOPTOSIS; CARCINOMA, RENAL CELL; CASPASE 3; CELL LINE, TUMOR; DIPEPTIDES; ENDOPLASMIC RETICULUM STRESS; HEAT-SHOCK PROTEINS; HUMANS; HYDROXAMIC ACIDS; KIDNEY NEOPLASMS; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASE INHIBITORS; MEMBRANE PROTEINS; POLY(ADP-RIBOSE) POLYMERASES; TRANSCRIPTION FACTOR CHOP; TUNICAMYCIN;

EID: 84866440474     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1986     Document Type: Article

References (43)

1. 2+-dependent and caspase-independent mechanism. J Biol Chem 286: 13638-13646, 2011.
2. Elbein AD: Inhibitors of the biosynthesis and processing of N-linked oligosaccharide chains. Annu Rev Biochem 56: 497-534, 1987.
3. Delom F, Fessart D and Chevet E: Regulation of calnexin sub-cellular localization modulates endoplasmic reticulum stress-induced apoptosis in MCF-7 cells. Apoptosis 12: 293-305, 2007. (Pubitemid 46169910)
4. Dricu A, Carlberg M, Wang M and Larsson O: Inhibition of N-linked glycosylation using tunicamycin causes cell death in malignant cells: role of down-regulation of the insulin-like growth factor 1 receptor in induction of apoptosis. Cancer Res 57: 543-548, 1997. (Pubitemid 27081677)
5. Hitomi J, Katayama T, Taniguchi M, Honda A, Imaizumi K and Tohyama M: Apoptosis induced by endoplasmic reticulum stress depends on activation of caspase-3 via caspase-12. Neurosci Lett 357: 127-130, 2004. (Pubitemid 38230947)
6. Nakagawa T, Zhu H, Morishima N, et al: Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β. Nature 403: 98-103, 2000. (Pubitemid 30038529)
7. Yu Q and Stamenkovic I: Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev 13: 35-48, 1999. (Pubitemid 29045114)
8. Arch R, Wirth K, Hofmann M, et al: Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 257: 682-685, 1992.
9. Desai B, Ma T, Zhu J and Chellaiah MA: Characterization of the expression of variant and standard CD44 in prostate cancer cells: identification of the possible molecular mech+anism of CD44/MMP9 complex formation on the cell surface. J Cell Biochem 108: 272-284, 2009.
10. Naor D, Sionov RV and Ish-Shalom D: CD44: structure, function, and association with the malignant process. Adv Cancer Res 71: 241-319, 1997. (Pubitemid 27197761)
11. Yamane N, Tsujitani S, Makino M, Maeta M and Kaibara N: Soluble CD44 variant 6 as a prognostic indicator in patients with colorectal cancer. Oncology 56: 232-238, 1999. (Pubitemid 29161293)
12. Wielenga VJ, Heider KH, Offerhaus GJ, et al: Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 53: 4754-4756, 1993. (Pubitemid 23326158)
13. Jung T, Gross W and Zoller M: CD44v6 coordinates tumor matrix-triggered motility and apoptosis resistance. J Biol Chem 286: 15862-15874, 2011.
14. Mielgo A, van Driel M, Bloem A, Landmann L and Gunthert U: A novel antiapoptotic mechanism based on interference of Fas signaling by CD44 variant isoforms. Cell Death Differ 13: 465-477, 2006.
15. Fini ME and Girard MT: The pattern of metalloproteinase expression by corneal fibroblasts is altered by passage in cell culture. J Cell Sci 97: 373-383, 1990. (Pubitemid 20361416)
16. Girard MT, Matsubara M, Kublin C, Tessier MJ, Cintron C and Fini ME: Stromal fibroblasts synthesize collagenase and stromelysin during long-term tissue remodeling. J Cell Sci 104: 1001-1011, 1993. (Pubitemid 23154307)
17. Sternlicht MD and Werb Z: How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17: 463-516, 2001. (Pubitemid 33096184)
18. Kessenbrock K, Plaks V and Werb Z: Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141: 52-67, 2010.
19. Smith KM, Gaultier A, Cousin H, Alfandari D, White JM and DeSimone DW: The cysteine-rich domain regulates ADAM protease function in vivo. J Cell Biol 159: 893-902, 2002. (Pubitemid 36008370)
20. Anderegg U, Eichenberg T, Parthaune T, et al: ADAM10 is the constitutive functional sheddase of CD44 in human melanoma cells. J Invest Dermatol 129: 1471-1482, 2009.
21. Huh MI, Lee YM, Seo SK, et al: Roles of MMP/TIMP in regulating matrix swelling and cell migration during chick corneal development. J Cell Biochem 101: 1222-1237, 2007.
22. Nagano O, Murakami D, Hartmann D, et al: Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca(2+) influx and PKC activation. J Cell Biol 165: 893-902, 2004. (Pubitemid 38821979)
23. Pacheco-Rodriguez G, Steagall WK, Crooks DM, et al: TSC2 loss in lymphangioleiomyomatosis cells correlated with expression of CD44v6, a molecular determinant of metastasis. Cancer Res 67: 10573-10581, 2007. (Pubitemid 350070834)
24. Dreier R, Grassel S, Fuchs S, Schaumburger J and Bruckner P: Pro-MMP-9 is a specific macrophage product and is activated by osteoarthritic chondrocytes via MMP-3 or a MT1-MMP/MMP-13 cascade. Exp Cell Res 297: 303-312, 2004. (Pubitemid 38798395)
25. Hernandez Rios M, Sorsa T, Obregon F, et al: Proteolytic roles of matrix metalloproteinase (MMP)-13 during progression of chronic periodontitis: initial evidence for MMP-13/MMP-9 activation cascade. J Clin Periodontol 36: 1011-1017, 2009.
26. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG and Earnshaw WC: Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371: 346-347, 1994. (Pubitemid 24300618)
27. Ferreira KS, Kreutz C, Macnelly S, et al: Caspase-3 feeds back on caspase-8, Bid and XIAP in type I Fas signaling in primary mouse hepatocytes. Apoptosis 17: 503-515, 2012.
28. Oyadomari S and Mori M: Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ 11: 381-389, 2004. (Pubitemid 38489416)
29. Ponta H, Sleeman J, Dall P, Moll J, Sherman L and Herrlich P: CD44 isoforms in metastatic cancer. Invasion Metastasis 14: 82-86, 1994.
30. Spessotto P, Rossi FM, Degan M, et al: Hyaluronan-CD44 interaction hampers migration of osteoclast-like cells by downregulating MMP-9. J Cell Biol 158: 1133-1144, 2002.
31. Samanna V, Ma T, Mak TW, Rogers M and Chellaiah MA: Actin polymerization modulates CD44 surface expression, MMP-9 activation, and osteoclast function. J Cell Physiol 213: 710-720, 2007. (Pubitemid 350058264)
32. Seipel D, Oliveira BC, Resende TL, et al: Toxoplasma gondii infection positively modulates the macrophages migratory molecular complex by increasing matrix metalloproteinases, CD44 and alpha v beta 3 integrin. Vet Parasitol 169: 312-319, 2010.
33. Chetty C, Vanamala SK, Gondi CS, Dinh DH, Gujrati M and Rao JS: MMP-9 induces CD44 cleavage and CD44 mediated cell migration in glioblastoma xenograft cells. Cell Signal 24: 549-559, 2012.
34. Ponta H, Sherman L and Herrlich PA: CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 4: 33-45, 2003. (Pubitemid 36077255)
35. Morrison H, Sherman LS, Legg J, et al: The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev 15: 968-980, 2001. (Pubitemid 32323547)
36. Wittig BM, Johansson B, Zoller M, Schwarzler C and Gunthert U: Abrogation of experimental colitis correlates with increased apoptosis in mice deficient for CD44 variant exon 7 (CD44v7). J Exp Med 191: 2053-2064, 2000.
37. Lesley J, English N, Perschl A, Gregoroff J and Hyman R: Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J Exp Med 182: 431-437, 1995.
38. Sleeman J, Rudy W, Hofmann M, Moll J, Herrlich P and Ponta H: Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity. J Cell Biol 135: 1139-1150, 1996. (Pubitemid 26403784)
39. Stevens JW, Palechek PL, Griebling TL, Midura RJ, Rokhlin OW and Cohen MB: Expression of CD44 isoforms in human prostate tumor cell lines. Prostate 28: 153-161, 1996. (Pubitemid 26110735)
40. Yu Q, Toole BP and Stamenkovic I: Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function. J Exp Med 186: 1985-1996, 1997. (Pubitemid 28013682)
41. Isacke CM and Yarwood H: The hyaluronan receptor, CD44. Int J Biochem Cell Biol 34: 718-721, 2002. (Pubitemid 34304161)
42. Kobayashi T: Suppression of matrix metalloproteinase-9 expression in undifferentiated, non-apoptotic keratinocytes is abrogated by the cleavage of poly(ADP-ribose) polymerase-1. Apoptosis 16: 1205-1216, 2011.
43. Yu Q and Stamenkovic I: Transforming growth factor-beta facilitates breast carcinoma metastasis by promoting tumor cell survival. Clin Exp Metastasis 21: 235-242, 2004. (Pubitemid 39158500)